Searched for
VIAL AND PEN FORMATS
Indian drugmakers flood market with cheaper versions of Novo's Ozempic, WegovyIndian drugmakers have launched affordable generic versions of popular diabetes and weight-loss drugs. This move significantly reduces trea...
23 Mar, 2026, 12.54 PM IST
Price alone won't push weight-loss, diabetes drug semaglutide sales: DoctorsLeading drugmakers including Sun Pharmaceuticals, Dr Reddy’s Laboratories, Zydus Lifesciences, Natco Pharma, Eris Lifesciences, USV, Glenma...
22 Mar, 2026, 11.19 AM IST
Natco, Eris Life to launch slimming shots in both Vial and Pen formatsNatco Pharma and Eris Lifesciences are launching generic semaglutide weight-loss injections. The companies are introducing both vial and pe...
21 Mar, 2026, 09.35 AM IST
Natco launches Rs 1,290 semaglutide in India, undercuts diabetes drug pricesNatco Pharma has launched a new generic semaglutide injection in India. This marks a significant step in making advanced diabetes treatment...
20 Mar, 2026, 09.57 AM IST
What’s powering Mounjaro’s rise to the top of Indian drug marketMounjaro has made a splash in Indian healthcare, emerging as the go-to solution for both diabetes management and weight loss. This remarkab...
03 Nov, 2025, 10.47 PM IST
Lilly to launch Mounjaro pen in India to compete with Novo's WegovyEli Lilly announced that India’s drug regulator has approved its Mounjaro KwikPen, a pre-filled injector pen for weight loss and diabetes t...
26 Jun, 2025, 01.15 PM IST
Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brandNovo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They ...
22 Apr, 2025, 11.50 AM IST